Vivimed Labs receives additional investment from Orbimed Asia

01 Jan 2018 Evaluate

Vivimed Labs has signed definitive agreements and received funds to facilitate additional investment of $7.5 million (follow on of $42.5 million invested in September 2017) by OrbiMed Asia into the company’s subsidiary, Vivimed Labs (Mascarene), the holding entity of the company’s API business.

The proceeds of this additional investment will be utilized to drive business growth and, increase the company’s profitability by organic and inorganic growth opportunities.

Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.



Vivimed Labs Share Price

7.00 -0.36 (-4.89%)
22-Jan-2026 12:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1622.65
Dr. Reddys Lab 1222.20
Cipla 1378.85
Zydus Lifesciences 885.25
Lupin 2176.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×